Sort
15,273 grants matching “antimicrobial resistance”
Innovative technologies to transform antibiotic discovery.
$6,621,136Deborah T Hung · Broad Institute, Inc. · U19 · FY2022 · AI
Center to develop innovative therapeutics to multidrug resistant high-threat bacterial agents
$6,521,325David S Perlin · Hackensack University Medical Center · U19 · FY2023 · AI
Innovative technologies to transform antibiotic discovery.
$6,495,548Deborah T Hung · Broad Institute, Inc. · U19 · FY2023 · AI
GH21-003, Advancing Public Health Research in Kenya
$6,329,348M Kariuki Njenga · Washington State University · U01 · FY2021 · GH
GH21-003, Advancing Public Health Research in Kenya
$6,288,488M Kariuki Njenga · Washington State University · U01 · FY2025 · GH
Development of Therapeutic Products for Biodefense, Anti-Microbial Resistant (AMR) Infections and Emerging Infectious Diseases
$6,265,409Andrew Tomaras · Forge Therapeutics, Inc. · N01 · FY2024 · AI
The Michigan Infectious Disease Genomics (MIDGE) Center
$6,233,451Adam Lauring · University Of Michigan At Ann Arbor · U19 · FY2024 · AI
Novel antimicrobials targeting MDR pathogens from animal microbial symbionts
$6,205,014David R Andes · University Of Wisconsin-Madison · U19 · FY2019 · AI
Novel antimicrobials targeting MDR pathogens from animal microbial symbionts
$6,020,201David R Andes · University Of Wisconsin-Madison · U19 · FY2020 · AI
STATISTICAL AND DATA COORDINATING CENTER FOR CLINICAL RESEARCH ON RESISTANT BACTERIA
$6,000,000Marian Ewell · The Emmes Company, Llc · N01 · FY2020 · AI
Novel antimicrobials targeting MDR pathogens from animal microbial symbionts
$5,982,443David R Andes · University Of Wisconsin-Madison · U19 · FY2021 · AI
Novel antimicrobials targeting MDR pathogens from animal microbial symbionts
$5,977,704David R Andes · University Of Wisconsin-Madison · U19 · FY2022 · AI
DEVELOPMENT OF BROAD SPECTRUM ANTIVIRALS
$5,974,418Urban Hans Ramstedt · Unither Virology, Llc · N01 · FY2012 · AI
Novel antimicrobials targeting MDR pathogens from animal microbial symbionts
$5,954,977David R Andes · University Of Wisconsin-Madison · U19 · FY2023 · AI
DEVELOPMENT OF BROAD SPECTRUM ANTIVIRALS
$5,814,899Urban Ramstedt · Unither Virology, Llc · N01 · FY2013 · AI
BIOINFORMATICS RESOURCE CENTERS FOR INFECTIOUS DISEASES
$5,800,429Rick Stevens · · N01 · FY2016 · AI
INTERAGENCY AGREEMENT BETWEEN THE NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES AND THE UNIFORMED SERVICES UNIVERSITY
$5,700,000Timothy Burgess · National Institute Of Allergy And Infectious Diseases · Y01 · FY2018 · AI
INTERAGENCY AGREEMENT BETWEEN THE NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES AND THE UNIFORMED SERVICES UNIVERSITY
$5,700,000Timothy Burgess · National Institute Of Allergy And Infectious Diseases · Y01 · FY2019 · AI
Development of Novel Antimicrobial Resistance Agents
$5,697,418Michael Eichberg · Achaogen, Inc. · N01 · FY2010 · AI
Targeted Clinical Trials for Antimicrobial Resistance
$5,696,248Vance Fowler · Duke University · N01 · FY2015 · AI
Development of Novel Agents for Gram-Negative Biodefense Pathogens
$5,500,227Trius Therapeutics, Inc. · N01 · FY2012 · AI
Vaccine and Treatment Evaluation Units
$5,485,363Nadine Georges Rouphael · Emory University · UM1 · FY2020 · AI
Innovative Platforms for Antimicrobial Therapy and Vaccine Development
$5,474,214Dennis L. Kasper · Harvard Medical School · U19 · FY2016 · AI
DEVELOPMENT OF IN VITRO DIAGNOSTICS FOR ANTIMICROBIAL RESISTANCE ESCHERICHIA COLI
$5,422,657Rangarajan Sampath · Siemens Healthcare Diagnostics Inc. · N01 · FY2023 · AI
Targeted Clinical Trial to Reduce the Risk of Antimicrobial Resistance
$5,405,643Victor Yu · University Of Pittsburgh At Pittsburgh · N01 · FY2013 · AI